News
Pandemic innovations that will outlast COVID
November 11, 2021
Hospitalists discuss process changes implemented during the pandemic that will likely survive it.
News
Tocilizumab shortage continues as pandemic wears on
August 19, 2021
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better – for now.
News
Myocarditis tied to COVID-19 shots more common than reported?
August 6, 2021
Myocarditis may develop rapidly in younger people, mostly after the second dose, while pericarditis affects older adults after the first or second dose. Both remain rare, new results show.
Opinion
Never prouder to be a hospitalist
August 3, 2021
Hospital medicine was the ideal specialty to manage the inpatient challenges over the last 18 months.
Opinion
FIND: A framework for success as a first-year hospitalist
- Allison K. Ashford, MD;
- And Teela Crecelius, MD;
- Rachna Rawal, MD;
- Ryan E. Nelson, MD
June 24, 2021
Beginning with the end in mind, will help you visualize your direction.
News
Hospital at Home: Delivering hospital-level care without the hospital
May 25, 2021
The future of HaH depends on development of a common payment model that will be adopted beyond the pandemic.
News
In-hospital glucose management program gives dramatic savings
May 10, 2021
“I’ve been advocating for endocrine hospitalists to be deployed nationally,” said Dr. Misha Zilbermint.
News
Arthritis drug may curb myocardial damage in acute STEMI
April 13, 2021
Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.
News
Virtual is the new real
- Chandra S. Lingisetty Md, MBA, MHCM;
- Rupesh Prasad Md, MPH, CPE, SFHM;
- Venkataraman Palabindala Md, MBA, FACP, SFHM
March 16, 2021
The need for a systematic telehealth deployment is far from being adequately fulfilled.
News
RECOVERY trial of COVID-19 treatments stops colchicine arm
March 8, 2021
Recruitment was halted for lack of efficacy in patients hospitalized with the disease.